BLACK DIAMOND THERAPEUTICS, INC. Gain (Loss) on Termination of Lease
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Gain (Loss) on Termination of Lease of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2023-03-09
- BLACK DIAMOND THERAPEUTICS, INC. gain (loss) on termination of lease for fiscal 2021 was $5.00K.
| Period end | Gain (Loss) on Termination of Lease | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | |||
| 2021-12-31 | $5.00K 10-K · filed 2023-03-09 | |||
| 2021-09-30 | $5.00K 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | $5.00K 10-Q · filed 2021-08-12 | |||
| 2021-06-15 | $5.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |